3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma
2
Sexual Dysfunction, Physiological
1
Pyridoxine-dependent epilepsy
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Liver Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Adenocarcinoma
1
Interventions
Temozolomide
29
Bevacizumab
15
Radiotherapy
13
antineoplaston AS 2-1
8
antineoplaston A10
8
Everolimus
7
Radiation
6
Erlotinib Hydrochloride
6
Radiotherapy, Intensity-Modulated
5
Lomustine
4
veliparib
3
palbociclib
3
Vorinostat
3
Sunitinib
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Carmustine
3
Carboplatin
3
temsirolimus
2
selinexor
2
poly ICLC
2
etoposide phosphate
2
cabozantinib
2
Sirolimus
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Imatinib Mesylate
2
Etoposide
2
Donepezil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Astrocytoma
×
Tadalafil
×
Clear all
No trials found.